Structure/function study of the biotransformation of fatty acids by human liver microsomes and recombinant UGT2B7.

被引:0
|
作者
Stewart, SN
Little, JM
Radominska-Pandya, A
Jude, AR
机构
[1] Univ Arkansas, Dept Chem, Little Rock, AR 72204 USA
[2] Univ Arkansas Med Sci, Dept Biochem, Little Rock, AR 72205 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
643-CHED
引用
收藏
页码:U198 / U198
页数:1
相关论文
共 50 条
  • [1] Biotransformation of arachidonic acid and its biologically active eicosanoids by human microsomes and recombinant UGT2B7.
    Jude, AR
    Graves, K
    Little, JM
    Radominska-Pandya, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U587 - U588
  • [2] Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7
    Tsoutsikos, P
    Miners, JO
    Stapleton, A
    Thomas, A
    Sallustio, BC
    Knights, KM
    BIOCHEMICAL PHARMACOLOGY, 2004, 67 (01) : 191 - 199
  • [3] S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen
    Bowalgaha, K
    Elliot, DJ
    Mackenzie, PI
    Knights, KM
    Swedmark, S
    Miners, JO
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (04) : 423 - 433
  • [4] Inhibition of UGT2B7 Enzyme Activity in Human and Rat Liver Microsomes by Herbal Constituents
    Abdullah, Nurul Huda
    Ismail, Sabariah
    MOLECULES, 2018, 23 (10):
  • [5] Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes
    Peterkin, Vincent C.
    Bauman, Jonathan N.
    Goosen, Theunis C.
    Menning, Lee
    Man, Michael Z.
    Paulauskis, Joseph D.
    Williams, J. Andrew
    Myrand, Scott P.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 64 (04) : 458 - 468
  • [6] Kinetic evaluation of UGT2B7 in human hepatic preparations: Explanation for liver microsomes underpredicting clearance?
    Engtrakul, JJ
    Fisher, MB
    Foti, RS
    Skaggs, SM
    Strelevitz, T
    DRUG METABOLISM REVIEWS, 2004, 36 : 200 - 200
  • [7] Kinetic characterisation of S-naproxen glucuronidation by human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7
    Knights, KM
    Tsoutsikos, P
    Bowalgaha, K
    Elliot, DJ
    Miners, JO
    DRUG METABOLISM REVIEWS, 2004, 36 : 135 - 135
  • [8] Involvement of CYP2B6 in the biotransformation of propofol by human liver microsomes
    TANG BingWANG JunkeFENG WanyuDepartment of AnesthesiologyFirst Affiliated HospitalChina Medical UniversityShenyang ChinaDepartment of Clinical Pharmacologythe First Affiliated HospitalChina Medical UniversityShenyang China
    沈阳药科大学学报, 2008, 25(S1) (S1) : 102 - 102
  • [9] Almokalant glucuronidation in human liver and kidney microsomes: evidence for the involvement of UGT1A9 and 2B7
    Gaiser, BK
    Lockley, DJ
    Staines, AG
    Baarnhielm, C
    Burchell, B
    XENOBIOTICA, 2003, 33 (11) : 1073 - 1083
  • [10] Glucuronidation of macelignan by human liver microsomes and expressed UGT enzymes: identification of UGT1A1 and 2B7 as the main contributing enzymes
    Liu, Hongming
    Wu, Zhufeng
    Ma, Zhiguo
    Wu, Baojian
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2014, 35 (09) : 513 - 524